Cargando…
MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARγ/NF-κB
Cardiac hypertrophy, a response of the heart to increased workload, is a major risk factor for heart failure. Myostatin (MSTN) is an inhibitor of myogenesis, regulating the number and size of skeletal myocytes. In recent years, cardiomyocyte autophagy also has been considered to be involved in contr...
Autores principales: | Qi, Hanping, Ren, Jing, Ba, Lina, Song, Chao, Zhang, Qianhui, Cao, Yonggang, Shi, Pilong, Fu, Bowen, Liu, Yongsheng, Sun, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951838/ https://www.ncbi.nlm.nih.gov/pubmed/31923740 http://dx.doi.org/10.1016/j.omtn.2019.12.003 |
Ejemplares similares
-
MiR‐103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts
por: Qi, Hanping, et al.
Publicado: (2019) -
Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats
por: Zhang, Qianhui, et al.
Publicado: (2018) -
Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction
por: Huang, Wei, et al.
Publicado: (2019) -
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
por: Zhao, Ting, et al.
Publicado: (2021) -
Neutrophil-like cell membrane-coated siRNA of lncRNA AABR07017145.1 therapy for cardiac hypertrophy via inhibiting ferroptosis of CMECs
por: Shi, Pilong, et al.
Publicado: (2021)